Conference Date: 22-23 Sep 2009
Conference Ref: N9-8209
Fee: £1150 + VAT
Venue: Harrington Hall Hotel, London
Summary
The demarcation between medicinal products and devices is becoming evermore important. In addition, with the convergence of emerging novel technologies the number of drug/device combination products and medicinal devices incorporating a medicinal substance are increasing. At the same time cell therapy and tissue engineered products are being combined with both pharmaceuticals and medical devices.
This seminar will provide practical advice on the borderline issues concerning these combination products and provide key guidance on the regulatory strategy to follow.
To book your place on this important Annual Seminar, please click here